Agilent Technologies

Agilent Technologies

Yahoo Finance • 7 days ago

Agilent Technologies (A) Expands Its Oncology Diagnostics Reach—Can Growth Keep Up?

Agilent Technologies Inc. (NYSE:A) just extended its diagnostics franchise into one of oncology's toughest corners. On July 23, the company said European regulators had certified its PD-L1 IHC 22C3 pharmDx test, Code SK006, as a companion... Full story

Yahoo Finance • 16 days ago

Notable healthcare headlines for the week: Eli Lilly, Molina Healthcare, and Roche in focus

Wall Street's major averages aimed to go higher on Friday but closed mixed as oil prices declined. The benchmark S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500#source=url_first_level%3Amarket-news%7Csection%3Amarket-news%7Csection_... Full story

Yahoo Finance • 17 days ago

Why Agilent Technologies (A) Is Up 5.4% After New FDA Nod For OPDIVO Cancer Test

In July 2026, Agilent Technologies received U.S. Food and Drug Administration approval for its PD-L1 IHC 28-8 pharmDx assay as a companion diagnostic to identify patients with several gastric and esophageal cancers who may be eligible for... Full story

Yahoo Finance • 18 days ago

1 Healthcare Stock to Research Further and 2 We Avoid

1 Healthcare Stock to Research Further and 2 We Avoid From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have been rewarded lately... Full story

Yahoo Finance • 19 days ago

In Vitro Toxicology Testing Market to Exceed $20.97 Billion by 2031 as Non-Animal Testing & AI Adoption Accelerate - Analysis by Product, Toxicity Endpoints & Type, Technology, Method, Service, Region

Company Logo Featuring Thermo Fisher Scientific, Agilent Technologies, Merck, Eurofins Scientific, Charles River Labs and Other Key Players In Vitro Toxicology Testing MarketIn Vitro Toxicology Testing Market Dublin, July 23, 2026 (GLOB... Full story

Yahoo Finance • 19 days ago

Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Approval expands PD-L1 testing to support treatment decisions with KEYTRUDA® (pembrolizumab) SANTA CLARA, Calif., July 23, 2026--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has received European Union (EU) cert... Full story

Yahoo Finance • 28 days ago

Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma

Test enables identification of patients whose tumors express PD-L1 and who may be eligible for treatment with OPDIVO® (nivolumab) or OPDIVO QVANTIG® SANTA CLARA, Calif., July 14, 2026--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A)... Full story

Yahoo Finance • last month

Penguin Solutions Non-GAAP EPS of $0.84 beats by $0.28, revenue of $479M beats by $57.64M

* Penguin Solutions press release [https://seekingalpha.com/pr/20575476-penguin-solutions-reports-q3-fiscal-2026-financial-results] (PENG [https://seekingalpha.com/symbol/PENG]): Q3 Non-GAAP EPS of $0.84 beats by $0.28. * Revenue of $4... Full story

Yahoo Finance • 2 months ago

Agilent (A) Stock Trades Up, Here Is Why

Agilent (A) Stock Trades Up, Here Is Why What Happened? Shares of life sciences tools company Agilent Technologies (NYSE:A) jumped 3.9% in the morning session after it announced the completion of its acquisition of Biocare Medical, a dea... Full story

Yahoo Finance • 2 months ago

Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies

GHO Capital Denver, CO and London, UK – 25 June 2026: Excellere Partners ("Excellere"), a Denver-based private equity firm specializing in partnering with entrepreneurs and management teams, and GHO Capital Partners LLP ("GHO"), a special... Full story

Yahoo Finance • 2 months ago

Agilent Completes Acquisition of Biocare Medical

Highly complementary combination expands Agilent's pathology portfolio and ability to serve customers across clinical and research settings Expected to be accretive to Agilent's top-line growth rate, margin profile and non-instrument reve... Full story

Yahoo Finance • 2 months ago

Global Laboratory Equipment Services Market Size/Share Worth USD 62.83 Billion by 2035 at a 8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Laboratory Equipment Services Market size & share revenue was valued at approximately... Full story

Yahoo Finance • 2 months ago

Global Automated Liquid Handling Systems Market Size/Share Worth USD 6.9 Billion by 2035 at a 9.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Automated Liquid Handling Systems Market size & share revenue was valued at approxima... Full story

Yahoo Finance • 2 months ago

Global Fluorescent In Situ Hybridization Probe Market Size/Share Worth USD 2.27 Billion by 2035 at a 7.9% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Fluorescent In Situ Hybridization Probe Market size & share revenue was valued at app... Full story

Yahoo Finance • 2 months ago

Madison Large Cap Fund Maintains Position on Agilent Technologies (A) Amid AI Fears

Madison Investments, an investment advisor, released its first-quarter 2026 investor letter for the "Madison Large Cap Fund". A copy of the letter is available to download here. The Madison Large Cap Fund (Class I) declined 2.7% in the qua... Full story

Yahoo Finance • 2 months ago

1 Profitable Stock to Target This Week and 2 We Avoid

1 Profitable Stock to Target This Week and 2 We Avoid Even if a company is profitable, it doesn't always mean it's a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their futu... Full story

Yahoo Finance • 2 months ago

Notable healthcare headlines for the week: GSK, Parabilis Medicines, and Novo Nordisk in focus

Wall Street traded higher on Friday as investors focused on the highly anticipated public debut of SpaceX, with enthusiasm surrounding the offering helping support gains across major U.S. equity indexes. The blue-chip Dow Jones Industrial... Full story

Yahoo Finance • 2 months ago

Agilent Technologies (A) Declined in Q1 Amid QIAGEN Acquisition Speculation

Impax Asset Management, an investment management firm based in London, specializing in sustainable investing, released its first-quarter 2026 investor letter for its “Impax Global Environmental Markets Fund”. A copy of the letter is availa... Full story

Yahoo Finance • 2 months ago

Agilent Receives FDA Approval for Expanded Use of PD-L1 IHC 22C3 pharmDx on Dako Omnis in Esophageal Squamous Cell Carcinoma, Triple-Negative Breast Cancer, Cervical Cancer, and Gastric or Gastroesophageal Junction Adenocarcinoma

Approval expands PD-L1 testing onto an automated workflow to support treatment decisions with KEYTRUDA® (pembrolizumab)¹,² SANTA CLARA, Calif., June 02, 2026--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the U... Full story

Yahoo Finance • 2 months ago

Is Now The Time To Look At Buying Agilent Technologies, Inc. (NYSE:A)?

Today we're going to take a look at the well-established Agilent Technologies, Inc. (NYSE:A). The company's stock received a lot of attention from a substantial price increase on the NYSE over the last few months. The recent rally in share... Full story